Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Cell Biochem ; 305(1-2): 153-61, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17629775

RESUMO

The citrus unshiu peel has been used traditionally as a medicine to improve bronchial and asthmatic conditions or cardiac and blood circulation in Korea, China, and Japan. Here, we report the effects of citrus unshiu peel water extract (CPWE) on the phorbol myristate acetate (PMA)+calcium ionophore A23187-induced hypoxia-inducible factor-1alpha (HIF-1alpha) activation and inflammatory cytokine production from the human mast cell line, HMC-1 cells. We compared CPWE with hesperidin, a common constituent of citrus unshiu. CPWE and hesperidin inhibited the PMA+A23187-induced HIF-1alpha expression and the subsequent production of vascular endothelial growth factor (VEGF). In addition, CPWE suppressed PMA+A23187-induced phosphorylation of the extracellular signal-regulated kinase (ERK). We also show that the increased cytokines interleukin (IL)-1beta, IL-8, and tumor necrosis factor (TNF)-alpha level was significantly inhibited by treatment of CPWE or hesperidin. In the present study, we report that CPWE and hesperidin are inhibitors of HIF-1alpha and cytokines on the mast cell-mediated inflammatory responses.


Assuntos
Citocinas/metabolismo , Hesperidina/farmacologia , Subunidade alfa do Fator 1 Induzível por Hipóxia/genética , Mediadores da Inflamação/metabolismo , Mastócitos/efeitos dos fármacos , Mastócitos/metabolismo , Calcimicina/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Citrus/química , Medicamentos de Ervas Chinesas/farmacologia , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Expressão Gênica/efeitos dos fármacos , Células HL-60 , Células HeLa , Humanos , Ionóforos/farmacologia , Acetato de Tetradecanoilforbol/farmacologia , Fator A de Crescimento do Endotélio Vascular/metabolismo
2.
J Ethnopharmacol ; 97(1): 83-8, 2005 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-15652280

RESUMO

Traditional Korean medicine, Cheongyeolsaseuptang (CYSST) has been widely applied as a treatment of rheumatoid arthritis (RA) in Korea. However, its effect in experimental models remains unknown. Recent reports suggest that in patients with RA, synovial mast cells increase in number and show signs of activation and production of cytokines. In this study, we investigated the effect of CYSST on production of cytokines by activated human mast cell line, HMC-1. When CYSST (1mg/ml) was added, the production of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8 was significantly inhibited about 37, 33.6, and 48%, respectively on phorbol 12-myristate 13-acetate (PMA) plus calcium ionophore A23187-stimulated HMC-1 cells. In addition, CYSST inhibited PMA plus A23187-induced activation of nuclear factor-kappaB. These findings may help understanding the mechanism of action of this medicine leading to control activated mast cells on inflammatory condition like RA.


Assuntos
Interleucina-6/antagonistas & inibidores , Interleucina-8/antagonistas & inibidores , Mastócitos/efeitos dos fármacos , Mastócitos/metabolismo , Medicina Tradicional do Leste Asiático , NF-kappa B/antagonistas & inibidores , Preparações de Plantas/farmacologia , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Linhagem Celular , Humanos , Interleucina-6/biossíntese , Interleucina-8/biossíntese , Coreia (Geográfico) , NF-kappa B/metabolismo , Preparações de Plantas/isolamento & purificação , Fator de Necrose Tumoral alfa/biossíntese
3.
Biol Pharm Bull ; 27(11): 1871-4, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15516740

RESUMO

OK205 is a traditional Korean prescription containing water-soluble chitosan, glucosamine HCl, chondroitin sulfate, and extract of herbal medicine, and has been used commercially to treat rheumatoid arthritis (RA). Because infiltrated mast cells and their mediators may contribute to the initiation and progression of the inflammatory process and matrix degradation of RA, we tested the inhibitory effects of OK205 on cytokine production in a human mast cell line (HMC-1 cells). Production of tumor necrosis factor-alpha was significantly decreased to 0.091+/-0.010 ng/ml after treatment of HMC-1 cells with OK205 100 microg/ml. The inhibition rate was about 43.57%. In addition, production of interleukin-6 in OK205 1 pg/ml-treated cells was 2.779+/-0.071 ng/ml, and the inhibition rate was about 50.22%. However, OK205 did not significantly inhibit the production of interleukin-8. These findings may help in understanding the mechanism of action of OK205, leading to control of mast cells in inflammatory conditions like RA.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Citocinas/biossíntese , Extratos Vegetais/farmacologia , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Quitosana , Sulfatos de Condroitina , Glucosamina , Humanos , Interleucina-6/antagonistas & inibidores , Interleucina-6/biossíntese , Interleucina-8/biossíntese , Medicina Tradicional do Leste Asiático , Fator de Necrose Tumoral alfa/antagonistas & inibidores
4.
Pharmacol Biochem Behav ; 79(2): 253-9, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15501300

RESUMO

Gamisipjundaebo-tang (GSDBT) has been used for the purpose of development of physical strength. In the present study, we investigated the immune enhancing effect induced by GSDBT. We investigated the anti-immobility effect of GSDBT via a forced-swimming test and blood biochemical parameters related to fatigue, glucose, blood urea nitrogen, lactic dehydrogenase, creatine kinase, and total protein. GSDBT (0.1 and 1 g/kg) was orally administered to mice for 14 days. After 7 and 14 days, as assessed through a forced-swimming test, immobility time was decreased in the GSDBT-administrated group (0.1 and 1 g/kg) in comparison with the control group. In addition, after 8 days, the contents of glucose and lactate dehydrogenase in the blood serum were increased, and contents of blood urea nitrogen were decreased in the GSDBT-administrated group. After 15 days, the contents of glucose were increased, and the contents of lactate dehydrogenase and blood urea nitrogen were decreased in the GSDBT-administrated group. However, it had no effect on the elevation of creatine kinase and total protein level. We also investigated the effect of GSDBT on the production of cytokines in human T-cell line, MOLT-4 cells, and splenocytes. GSDBT significantly increased interferon (IFN)-gamma and interleukin (IL)-2 levels compared with the media control but did not affect IL-4. GSDBT increased the protein expression of IFN-gamma in MOLT-4 cells. These results suggest that GSDBT may be useful in immune function improvement and may also have antifatigue properties.


Assuntos
Fatores Imunológicos/farmacologia , Plantas Medicinais , Animais , Linhagem Celular , Fadiga/tratamento farmacológico , Humanos , Imobilização , Interferon gama/biossíntese , Interleucina-2/biossíntese , Interleucina-4/biossíntese , Masculino , Medicina Tradicional do Leste Asiático , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos ICR , Fitoterapia , Natação , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia
5.
Biol Pharm Bull ; 27(10): 1521-6, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15467188

RESUMO

WooKiEum (WKE) has been used for the purpose of the development of increased immune-system strength in Korea. In the present study, we examined the anti-immobility effect of WKE on the forced swimming test (FST), and then measured blood biochemical parameters related to fatigue: glucose (Glc), blood urea nitrogen (BUN), lactic dehydrogenase (LDH), creatinine, and total protein (TP). WKE (0.1, 1 g/kg) was administered orally to mice for 7 d. After 2 d, the immobility time was decreased in the WKE-administered group. After 7 d, the immobility time was significantly decreased in the WKE-administered group (64.6+/-9.0 s for 0.1 g/kg) in comparison with the control group (101.3+/-32.7 s). In addition, amount of Glc in the blood serum was increased, whereas the contents of BUN, LDH and TP decreased in the WKE-administered group. Next, we investigated the effect of WKE on the production of cytokines in a human T-cell line, MOLT-4 cells and mouse peritoneal macrophages. WKE (1 mg/ml) significantly increased interferon (IFN)-gamma and TNF-alpha production compared with the media control (about 2.2-fold for IFN-gamma, about 1.7-fold for TNF-alpha, p<0.05) after 24 h. WKE increased the protein expression of IFN-gamma in MOLT-4 cells. These results suggest that WKE may be useful in immune function improvement.


Assuntos
Adjuvantes Imunológicos/farmacologia , Extratos Vegetais/farmacologia , Animais , Glicemia/análise , Nitrogênio da Ureia Sanguínea , Western Blotting , Linhagem Celular Tumoral , Creatina Quinase/sangue , Citocinas/biossíntese , Relação Dose-Resposta a Droga , Ensaio de Imunoadsorção Enzimática , Humanos , Coreia (Geográfico) , L-Lactato Desidrogenase/sangue , Macrófagos Peritoneais/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos ICR , Atividade Motora/efeitos dos fármacos , Natação
6.
J Ethnopharmacol ; 90(2-3): 253-9, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15013189

RESUMO

Kuibitang (KBT) is clinically used to treat patients suffering from chronic fatigue syndrome (CFS) in South Korea. However, its effect has not been investigated experimentally. Recent reports have shown that CFS patients display an altered cytokine production. We examined the effect of KBT on lipopolysaccharide (LPS)-induced various cytokines production in peripheral blood mononuclear cells (PBMC) of CFS patients and healthy controls. KBT (1 mg/ml) significantly inhibited LPS-induced tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 production in PBMC of CFS patients. However, LPS-induced interferon-gamma production was significantly increased by KBT (0.01 mg/ml). These results provide evidence of a novel activity of the KBT that regulate cytokines production related with CFS.


Assuntos
Adjuvantes Imunológicos/farmacologia , Citocinas/antagonistas & inibidores , Citocinas/biossíntese , Síndrome de Fadiga Crônica/metabolismo , Leucócitos Mononucleares/efeitos dos fármacos , Lipopolissacarídeos/farmacologia , Medicina Tradicional Chinesa , Medicina Kampo , Adulto , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Células Cultivadas , Relação Dose-Resposta Imunológica , Síndrome de Fadiga Crônica/tratamento farmacológico , Humanos , Leucócitos Mononucleares/citologia , Leucócitos Mononucleares/metabolismo , Pessoa de Meia-Idade , Fitoterapia/métodos , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Estatísticas não Paramétricas
7.
Immunopharmacol Immunotoxicol ; 25(4): 491-501, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14686792

RESUMO

Bojungikki-tang (BIT) has been widely used to treat patients suffering from chronic fatigue syndrome (CFS). However, its effect has not been yet investigated experimentally. Based upon the clinical presentation of CFS, we hypothesized that cytokines may play a role in the pathogenesis of the disease. We studied the effect of BIT on lipopolysaccharide (LPS)-induced various cytokines production in peripheral blood mononuclear cells (PBMC) of CFS patients. Bojungikki-tang (1 mg/mL) significantly inhibited LPS-induced tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-10, transforming growth factor (TGF)-beta1 production by 63.55% +/- 0.19%, 55.06% +/- 0.27%, 48.23% +/- 0.48%, 54.09% +/- 0.76%, respectively (P < 0.05). Bojungikki-tang showed a slightly lower inhibitory effect of LPS-induced Interferon (IFN)-gamma production. These results suggest that BIT may be useful in treating fatigue associated with chronic diseases.


Assuntos
Citocinas/biossíntese , Síndrome de Fadiga Crônica/imunologia , Leucócitos Mononucleares/efeitos dos fármacos , Leucócitos Mononucleares/imunologia , Extratos Vegetais/farmacologia , Adulto , Síndrome de Fadiga Crônica/tratamento farmacológico , Síndrome de Fadiga Crônica/etiologia , Humanos , Técnicas In Vitro , Interferon gama/biossíntese , Interleucina-10/biossíntese , Interleucina-6/biossíntese , Lipopolissacarídeos/farmacologia , Pessoa de Meia-Idade , Fitoterapia , Fator de Crescimento Transformador beta/biossíntese , Fator de Crescimento Transformador beta1 , Fator de Necrose Tumoral alfa/biossíntese
8.
Inflammation ; 27(3): 129-35, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12875366

RESUMO

Mast cells are key as effector cells in the early phase allergic inflammation and in diverse immunological and pathological processes. Forsythia fructus (F. fructus) has used as a traditional medicine for inflammatory diseases. In the present study, we determined the effect of F. fructus extracts on compound 48/80-induced paw oedema and vascular permeability in vivo. In addition, we investigated in vitro whether F. fructus has inhibitory effects on compound 48/80-induced histamine releases from rat peritoneal mast cells (RPMC), and on phorbol 12-myristate 13-acetate (PMA) plus A23187-induced tumor necrosis factor-alpha (TNF-alpha) releases from human mast cells (HMC-1). In mice orally administrered F. fructus (100 microg/g) for 1 h, compound-48/80-induced oedema and vascular permeability were significantly reduced rather than those receiving intravenous injection of ketotifen, mast cell stabilizer. F. fructus dose-dependently inhibited the histamine release induced by compound 48/80 from RPMCs. Moreover, F. fructus had no cytotoxic effects on cell viability and had inhibitory effects on TNF-alpha secretion from HMC-1. These results suggest that F. fructus is a potential herb medicine for treatment of inflammatory diseases through downmodulating mast cell activation.


Assuntos
Antialérgicos/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Edema/prevenção & controle , Forsythia/fisiologia , Hipersensibilidade/prevenção & controle , Mastócitos/efeitos dos fármacos , Animais , Antialérgicos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Edema/metabolismo , Humanos , Hipersensibilidade/metabolismo , Masculino , Mastócitos/metabolismo , Camundongos , Camundongos Endogâmicos ICR , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Ratos
9.
Comp Biochem Physiol C Toxicol Pharmacol ; 135(2): 197-203, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12860059

RESUMO

Using mouse peritoneal macrophages, we have examined the mechanism by which, Smilacis rhizoma (SR) regulates nitric oxide (NO) production. When SR was used in combination with recombinant interferon-gamma (rIFN-gamma), there was a marked cooperative induction of NO production. However, SR had no effect on NO production by itself. The increased production of NO from rIFN-gamma plus SR-stimulated cells was almost completely inhibited by pre-treatment with pyrrolidine dithiocarbamate (PDTC), an inhibitor of nuclear factor kappa B (NF-kappaB). Furthermore, treatment of peritoneal macrophages with rIFN-gamma plus SR caused a significant increase in tumor necrosis factor-alpha (TNF-alpha) production. PDTC also decreased the effect of SR on TNF-alpha production significantly. These findings demonstrate that SR increases the production of NO and TNF-alpha by rIFN-gamma-primed macrophages and suggest that NF-kappaB plays a critical role in mediating these effects of SR.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Macrófagos Peritoneais/efeitos dos fármacos , Macrófagos Peritoneais/metabolismo , Óxido Nítrico/biossíntese , Extratos Vegetais/farmacologia , Prolina/análogos & derivados , Fator de Necrose Tumoral alfa/biossíntese , Animais , Células Cultivadas , Relação Dose-Resposta a Droga , Interferon gama/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , NF-kappa B/metabolismo , Extratos Vegetais/antagonistas & inibidores , Prolina/farmacologia , Tiocarbamatos/farmacologia , ômega-N-Metilarginina/farmacologia
10.
J Ethnopharmacol ; 83(1-2): 123-8, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12413717

RESUMO

Gamcho-Sasim-Tang (GS-Tang) is a traditional Chinese medication, which has been successfully used in Korea for the treatment of Adamantiades-Behçet's disease (ABD). We investigated the modulation effects of GS-Tang on cytokine production from phytohaemagglutinin-stimulated peripheral blood mononuclear cells of Behçet's patients. ABD is a systemic inflammatory disorder and might involve immune dysfunction. Cytokines involved in the regulation of inflammatory reactions and immune responses may play a role in the pathogenesis of ABD. GS-Tang (1 mg/ml) significantly inhibited the production of proinflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta), compared to absence of GS-Tang (by 42.0+/-6.6% inhibition for TNF-alpha and 95.9+/-5.7% for IL-1 beta, P<0.05). GS-Tang also inhibited the production of IFN-gamma, immunoregulatory T helper cell type 1 cytokine, by 80.2+/-5.3% (P=0.001). The inhibitory effects of GS-Tang on cytokine production showed dose-dependent manner. Our results suggest that GS-Tang might have anti-inflammatory and immuno-regulatory effects through the cytokine modulation.


Assuntos
Adjuvantes Imunológicos/farmacologia , Anti-Inflamatórios/farmacologia , Síndrome de Behçet/tratamento farmacológico , Citocinas/efeitos dos fármacos , Medicamentos de Ervas Chinesas/farmacologia , Fitoterapia , Adjuvantes Imunológicos/administração & dosagem , Adjuvantes Imunológicos/uso terapêutico , Adulto , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/uso terapêutico , Feminino , Humanos , Interferon gama/efeitos dos fármacos , Interleucina-1/metabolismo , Leucócitos Mononucleares/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Fator de Necrose Tumoral alfa/efeitos dos fármacos
11.
Biol Pharm Bull ; 25(9): 1142-6, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12230105

RESUMO

Oldenlandia diffusa (OD) has been used to treat malignant tumors. In this study using mouse peritoneal macrophages, we have examined the mechanism by which OD regulates nitric oxide (NO) production. When OD (1 mg/ml) was used in combination with 10 U/ml of recombinant interferon-gamma (rIFN-gamma), there was a marked cooperative induction of NO production (36.13+/-7.12 microM) by the Griess method (nitrite). Treatment of macrophages with rIFN-gamma plus OD (1 mg/ml) caused a significant increase in tumor necrosis factor-alpha (TNF-alpha) production (4.49+/-1.43 ng/ml) by enzyme-linked immunosorbent assay. The increased production of NO and TNF-alpha from rIFN-gamma-plus OD-stimulated cells was almost completely inhibited by pretreatment with 100 microM of pyrrolidine dithiocarbamate (PDTC), an inhibitor of nuclear factor kappa B (NF-kappaB). PDTC also inhibited phosphorylation of IkappaB in rIFN-gamma-plus OD-stimulated cells. These findings demonstrate that OD increases the production of NO and TNF-alpha by rIFN-gamma-primed macrophages and suggest that NF-kappaB plays a critical role in mediating these effects of OD.


Assuntos
Macrófagos Peritoneais/enzimologia , Óxido Nítrico Sintase/biossíntese , Oldenlandia , Animais , Relação Dose-Resposta a Droga , Indução Enzimática/efeitos dos fármacos , Indução Enzimática/fisiologia , Humanos , Macrófagos Peritoneais/efeitos dos fármacos , Camundongos , Extratos Vegetais/farmacologia , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...